An alternative splicing product of the lamin A/C gene lacks exon 10

被引:151
作者
Machiels, BM [1 ]
Zorenc, AHG [1 ]
Endert, JM [1 ]
Kuijpers, HJH [1 ]
vanEys, GJJM [1 ]
Ramaekers, FCS [1 ]
Broers, JLV [1 ]
机构
[1] UNIV LIMBURG,DEPT MOLEC GENET & CELL BIOL,6200 MD MAASTRICHT,NETHERLANDS
关键词
D O I
10.1074/jbc.271.16.9249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of the A-type lamins was studied in the lung adenocarcinoma cell line GLC-A1. A-type lamins, consisting of lamin A and C, are two products arising from the same gene by alternative splicing. Northern blotting showed in GLC-A1 a relatively low expression level of lamin C and an even lower expression level of lamin A as compared to other adenocarcinoma cell lines, Immunofluorescence studies revealed highly irregular nuclear inclusions of lamin A, suggesting protein or gene expression abnormalities, Reverse transcriptase-polymerase chain reaction-based cDNA analysis followed by sequencing indicated the presence of an as yet unidentified alternative splicing product of the lamin A/C gene. This product differs from lamin A by the absence of the 5' part of exon 10 (90 nucleotides). Therefore we propose to designate this product lamin A Delta 10. Deletion of the 30 amino acids encoded by exon 10 was predicted to result in a shift in pi of the protein from 7.4 to approximately 8.6, which was confirmed by two-dimensional immunoblotting. mRNA analysis in a variety of cell lines, normal colon tissue as well as carcinomas demonstrated the presence of lamin A Delta 10 in all samples examined, suggesting its presence in a variety of cell types.
引用
收藏
页码:9249 / 9253
页数:5
相关论文
共 42 条
[1]   CHARACTERIZATION OF THE STATE OF DIFFERENTIATION OF 6 NEWLY ESTABLISHED HUMAN NON-SMALL-CELL LUNG-CANCER CELL-LINES [J].
BEPLER, G ;
KOEHLER, A ;
KIEFER, P ;
HAVEMANN, K ;
BEISENHERZ, K ;
JAQUES, G ;
GROPP, C ;
HAEDER, M .
DIFFERENTIATION, 1988, 37 (02) :158-171
[2]   IDENTIFICATION OF A NUCLEAR PROTEIN MATRIX [J].
BEREZNEY, R ;
COFFEY, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 60 (04) :1410-1417
[3]  
BIEDLER JL, 1973, CANCER RES, V33, P2643
[4]  
BRIDGER JM, 1993, J CELL SCI, V104, P297
[5]  
BROERS JLV, 1993, AM J PATHOL, V143, P211
[6]  
BROERS JLV, 1988, J CELL SCI, V91, P91
[7]  
BROWER M, 1986, CANCER RES, V46, P798
[8]  
CANCE WG, 1992, J EXP CLIN CANC RES, V11, P233
[9]  
CARNEY DN, 1985, CANCER RES, V45, P2913
[10]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299